GNTW yields 66.67% · JNJ yields 2.13%● Live data
📍 GNTW pulled ahead of the other in Year 1
Combined, GNTW + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GNTW + JNJ for your $10,000?
Stemtech Corporation, a stem cell nutrition company, develops and sells various dietary supplements. It offers stemrelease3, a stem cell enhancer, which supports the body's natural renewal system, a general sense of wellbeing, and telomeres health, as well as promotes youthful and healthy aging; StemFlo that supports optimal blood and healthy stem cell flow, protect the cardiovascular system from oxidative damage, boosts vitality, and promotes healthy aging; and MigraStem, a natural source of potent antioxidants, phytonutrients, fiber, and polysaccharides, which optimizes the migration of stem cells, enhance the immune system performance, support detoxification and anti-oxidative functions, enhances healthy longevity, and provide vitality and well-being. The company also provides OraStem that protects, strengthens, rejuvenates, restores, and supports teeth and gum function from the cellular level, as well as offer anti-oxidative and anti-microbial protection, supports tooth strength with essential minerals, helps to remove stains, brightens teeth in a natural and non-abrasive way, and freshens breath; and D-Fuze, an electromagnetic frequency (EMF) filter that protects the body from potential harm by dispersing EMFs to lower the specific absorption rate. It serves customers in Australia, Canada, Ecuador, Malaysia, Mexico, Namibia, New Zealand, the Philippines, Singapore, South Africa, Taiwan, Togo, and the United States. The company was founded in 2005 and is based in Miramar, Florida.
Full GNTW Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.